BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27568980)

  • 1. Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.
    Harjes U; Bridges E; Gharpure KM; Roxanis I; Sheldon H; Miranda F; Mangala LS; Pradeep S; Lopez-Berestein G; Ahmed A; Fielding B; Sood AK; Harris AL
    Oncogene; 2017 Feb; 36(7):912-921. PubMed ID: 27568980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.
    Harjes U; Bridges E; McIntyre A; Fielding BA; Harris AL
    J Biol Chem; 2014 Aug; 289(33):23168-23176. PubMed ID: 24939870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma.
    Zhang Q; Li Y; Miao C; Wang Y; Xu Y; Dong R; Zhang Z; Griffin BB; Yuan C; Yan S; Yang X; Liu Z; Kong B
    Cancer Lett; 2018 Sep; 432():144-155. PubMed ID: 29879497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FP3: a novel VEGF blocker with antiangiogenic effects in vitro and antitumour effects in vivo.
    Jin K; He K; Teng F; Li G; Wang H; Han N; Xu Z; Cao J; Wu J; Yu D; Teng L
    Clin Transl Oncol; 2011 Dec; 13(12):878-84. PubMed ID: 22126731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma.
    Ghelfi E; Yu CW; Elmasri H; Terwelp M; Lee CG; Bhandari V; Comhair SA; Erzurum SC; Hotamisligil GS; Elias JA; Cataltepe S
    Am J Pathol; 2013 Apr; 182(4):1425-33. PubMed ID: 23391391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
    Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E
    Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of growth factor receptor bound protein 7 suppresses angiogenesis by inhibiting the secretion of vascular endothelial growth factor A in ovarian cancer cells.
    Xu Q; Liu Z; Zhu ZQ; Fan Y; Chen R; Xie XH; Cheng M
    Bioengineered; 2021 Dec; 12(2):12179-12190. PubMed ID: 34783299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
    Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
    Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
    Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
    Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOHLH2 Suppresses Angiogenesis by Downregulating HIF1α Expression in Breast Cancer.
    Cui W; Xiao Y; Zhang R; Zhao N; Zhang X; Wang F; Liu Y; Zhang X; Hao J
    Mol Cancer Res; 2021 Sep; 19(9):1498-1509. PubMed ID: 34158392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway.
    Bai L; Wang A; Zhang Y; Xu X; Zhang X
    Exp Cell Res; 2018 May; 366(2):161-171. PubMed ID: 29548748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.
    Zhang Y; Zhang Y; Wang J; Gu H
    Biomed Res Int; 2020; 2020():5391058. PubMed ID: 33145353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
    Di Martile M; Gabellini C; Desideri M; Matraxia M; Farini V; Valentini E; Carradori S; Ercolani C; Buglioni S; Secci D; Andreazzoli M; Del Bufalo D; Trisciuoglio D
    J Exp Clin Cancer Res; 2020 Jun; 39(1):103. PubMed ID: 32498717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary compound glycyrrhetinic acid suppresses tumor angiogenesis and growth by modulating antiangiogenic and proapoptotic pathways in vitro and in vivo.
    Li J; Tang F; Li R; Chen Z; Lee SM; Fu C; Zhang J; Leung GP
    J Nutr Biochem; 2020 Mar; 77():108268. PubMed ID: 31830590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
    Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
    Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.